• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $ASTC

    Astrotech Corporation (DE)

    Subscribe to $ASTC
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation operates as a science and technology development and commercialization company worldwide. It operates through three segments, Astrotech Technologies, Inc. (ATI), 1st Detect Corporation (1st Detect), and AgLAB Inc (AgLAB). The ATI segment owns and licenses the AMS Technology, the platform mass spectrometry technology. The 1st Detect segment manufactures explosives and narcotics trace detectors for use at airports, secured facilities, and borders. This segment provides TRACER 1000, a mass spectrometer based explosives trace detector to replace the explosives trace detectors used at airports, cargo and secured facilities, and borders. The AgLAB segment develops AgLAB-1000, a mass spectrometer for use in the hemp and cannabis market. It also develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. Astrotech Corporation was incorporated in 1984 is based in Austin, Texas.

    IPO Year:

    Exchange: NASDAQ

    Website: astrotechcorp.com

    Recent Analyst Ratings for Astrotech Corporation (DE)

    DatePrice TargetRatingAnalyst
    See more ratings

    Astrotech Corporation (DE) Press Releases

    Fastest customizable press release news feed in the world

    View All

    Astrotech Corporation Appoints Nihanth Badugu as Chief Operating Officer

    AUSTIN, Texas, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech"), today announced that it has appointed Nihanth Badugu as Chief Operating Officer ("COO") of the Company. Mr. Badugu's appointment is effective as of August 13, 2025. "The Board is thrilled to promote Mr. Badugu to Chief Operating Officer," stated Thomas B. Pickens III, Chairman and Chief Executive Officer of Astrotech Corporation. "Nihanth has been an invaluable asset to Astrotech since joining us in 2023. His dedication to operational excellence and program management has significantly advanced our objectives. We are confident in his ability to lead our operations as COO a

    8/18/25 4:45:00 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Announces Deployment of EN-SCAN Devices to Transform Instant, On-Site Environmental Field Monitoring

    AUSTIN, Texas, Aug. 15, 2025 (GLOBE NEWSWIRE) -- -- Astrotech Corporation ("Astrotech" or the "Company") (NASDAQ:ASTC) announced today that it has introduced its new EN-SCAN product line ("EN-SCAN") of ultra-portable rugged environmental testing instruments, featuring its proprietary ATi Gas Chromatograph Column ("GC") and ATi Mass Spectrometer Technology™ ("MS") through its wholly owned subsidiary, EN-SCAN, Inc. By deploying EN-SCAN devices from Astrotech, customers gain access to real-time results and on-demand reporting, enabling continuous monitoring and immediate response in critical applications such as environmental compliance, refining, manufacturing, emergency response, and indu

    8/15/25 8:45:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference in September 2025

    AUSTIN, Texas, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech") today announced that Thomas B. Pickens III, Chairman and Chief Executive Officer, and Jennifer Cañas, Chief Financial Officer, will host investor meetings on Tuesday, September 9, 2025 as part of the H.C. Wainwright 27th Annual Global Investment Conference in New York City taking place at the Lotte New York Palace Hotel. Investors can register and request meetings with management via their HC Wainwright representative or Astrotech Investor Relations at [email protected]. About Astrotech Corporation Astrotech Corporation is a mass spectrometry company that creates, opera

    8/13/25 4:45:00 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Subsidiary 1st Detect Announces First Tracer 1000 NTD System Sale in Vietnam

    AUSTIN, Texas , July 31, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC), a provider of next generation security screening and detection technologies based on Mass Spectrometry ("Mass Spec"), today announced the first sale and deployment of its TRACER 1000™ Narcotics Trace Detector ("TRACER 1000 NTD™") in Vietnam, by way of its subsidiary 1st Detect. This milestone marks a significant step in expanding the 1st Detect footprint across Southeast Asia and reinforces its commitment to enhancing narcotics trace detection inspection capabilities in global emerging markets. "This first NTD system in Vietnam demonstrates Astrotech's growing presence in Asia and the increasing trust

    7/31/25 4:45:00 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation Appoints Jennifer Cañas as Chief Financial Officer

    AUSTIN, Texas, May 28, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or ("Astrotech"), today announced that it has appointed Jennifer Cañas as Chief Financial Officer ("CFO") of the Company. Ms. Cañas' appointment is effective as of May 22, 2025. "The Board is delighted to promote Ms. Cañas to Chief Financial Officer," stated Thomas B. Pickens III, Chairman and Chief Executive Officer of Astrotech Corporation. "I have worked with Ms. Cañas since 2022 and have found her to be hard working, competent and knowledgeable. Management and the Board of Directors are excited to promote Jennifer to this position as she demonstrated strong leadership and delivered solid

    5/28/25 5:25:00 PM ET
    $ASTC
    $HTO
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Water Supply
    Utilities

    Astrotech Reports Third Quarter of Fiscal Year 2025 Financial Results

    AUSTIN, Texas, May 13, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech") reported its financial results for the third quarter of fiscal year 2025, which ended March 31, 2025. Thomas B. Pickens, III, Astrotech's Chairman, Chief Executive Officer and Chief Technology Officer, said, "Our customizable, portable and field updatable mass spectrometry instruments have the potential to be a game changer in a growing list of large end markets such as airport security and cargo scanning, narcotics detection, environmental monitoring and chemical processing. I am very proud of our team's accomplishments, as we now have launched four product lines that we bel

    5/13/25 4:30:00 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    1st Detect Unveils Enhanced TRACER 1000 Narcotics Trace Detector Intended to Combat Synthetic Opiates and Novel Psychoactive Substances

    AUSTIN, Texas, March 10, 2025 (GLOBE NEWSWIRE) --  Astrotech Corporation (NASDAQ:ASTC) today announced the launch of its enhanced TRACER 1000™ Narcotics Trace Detector ("TRACER 1000 NTD") from its 1st Detect subsidiary. This innovative mobilized mass spectrometer is specifically configured to screen for the full range of synthetic opiates and novel psychoactive substances ("NPS"), delivering accuracy and speed to counter the global drug crisis. Improving Drug Detection with Advanced Mass Spectrometry The latest iteration of the TRACER 1000 NTD represents a significant leap forward in portable trace detection. Unlike conventional methods, the TRACER 1000 NTD leverages cutting-edge mass sp

    3/10/25 8:30:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Creates New Subsidiary EN-SCAN, Inc.

    AUSTIN, Texas, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) announced today that it has created a new wholly owned subsidiary, EN-SCAN, Inc. ("EN-SCAN"), to manufacture and sell a new line of instruments built for environmental testing applications using its proprietary ATi Gas Chromatograph ("GC") and Astrotech Mass Spectrometer Technology™ ("MS"). The EN-SCAN product line has been designed for outdoor field work that can be used on-site for real-time air, water, and soil analysis providing instant feedback for accurate contamination source location and migration. "EN-SCAN has been developed to fill a gap in the environmental testing market needing a durable and

    2/28/25 8:30:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Reports Second Quarter of Fiscal Year 2025 Financial Results

    AUSTIN, Texas, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech") reported its financial results for the second quarter of fiscal year 2025, which ended December 31, 2024. Financial Highlights & Recent Developments Fiscal year 2025 Q2 revenue of $295 thousand is primarily generated by activities supporting work with the U.S. Department of Homeland Security ("DHS") to demonstrate the capabilities of our TRACER 1000™ for advanced explosives trace detection.On January 14, 2025, our wholly owned subsidiary, 1st Detect Corporation ("1st Detect"), announced that it was awarded research and development contract 70RSAT24CB0000015 with the DHS to

    2/14/25 8:45:56 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Jaime Hinojosa Resigns as Chief Financial Officer to Work in Family Business

    AUSTIN, Texas, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") announced the resignation of its Chief Financial Officer, Jaime Hinojosa, effective February 14, 2025.   Mr. Hinojosa will continue to serve in the CFO role until February 14, 2025, and after that time will provide transition services to the Company on a consulting basis through June 30, 2025. In connection with this development, the Company and its Board of Directors have appointed Ryan Polk to serve as interim Chief Financial Officer. "I will be moving to Houston to be closer to family and to work for our family business," said Mr. Hinojosa. "I am grateful to Tom Pickens,

    1/24/25 8:30:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation (DE) Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 4 filed by Chief Financial Officer Canas Jennifer

    4/A - ASTROTECH Corp (0001001907) (Issuer)

    6/5/25 4:42:15 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Chief Financial Officer Canas Jennifer was granted 5,250 shares (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    6/4/25 5:05:17 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 3 filed by new insider Canas Jennifer

    3 - ASTROTECH Corp (0001001907) (Issuer)

    6/4/25 5:02:53 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Mcfarland Robert N was granted 3,000 shares, increasing direct ownership by 28% to 13,900 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    5/16/25 11:38:34 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Stober Eric was granted 3,000 shares, increasing direct ownership by 41% to 10,331 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    5/16/25 10:47:45 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    CEO Pickens Thomas Boone Iii was granted 50,000 shares, increasing direct ownership by 38% to 181,385 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    5/16/25 10:46:04 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Halinski John William was granted 3,000 shares (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    5/16/25 10:44:55 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Winn Charles Arch was granted 3,000 shares, increasing direct ownership by 337% to 3,889 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    5/16/25 10:43:42 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Wilkinson Thomas Wiley was granted 3,000 shares, increasing direct ownership by 14% to 23,862 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    5/16/25 10:31:09 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    New insider Polk Ryan claimed no ownership of stock in the company (SEC Form 3)

    3 - ASTROTECH Corp (0001001907) (Issuer)

    1/24/25 7:05:31 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation (DE) Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Becker James Frank bought $19,675 worth of shares (2,034 units at $9.67), increasing direct ownership by 14% to 16,121 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    5/30/24 9:16:58 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Hinojosa Jaime bought $8,541 worth of shares (900 units at $9.49), increasing direct ownership by 13% to 7,881 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    5/28/24 9:46:54 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Wilkinson Thomas Wiley bought $10,536 worth of shares (1,109 units at $9.50), increasing direct ownership by 6% to 20,862 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    5/21/24 12:54:36 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Russler Daniel T Jr bought $3,259 worth of shares (387 units at $8.42), increasing direct ownership by 3% to 14,904 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    3/19/24 2:09:37 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mcfarland Robert N bought $10,072 worth of shares (1,185 units at $8.50), increasing direct ownership by 12% to 10,900 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    3/18/24 3:18:18 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Becker James Frank bought $12,200 worth of shares (1,488 units at $8.20), increasing direct ownership by 12% to 14,087 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    3/18/24 1:53:13 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Russler Daniel T Jr bought $4,145 worth of shares (500 units at $8.29), increasing direct ownership by 4% to 14,517 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    3/14/24 12:09:48 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Wilkinson Thomas Wiley bought $10,765 worth of shares (1,300 units at $8.28), increasing direct ownership by 7% to 19,753 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    3/14/24 9:00:43 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Becker James Frank bought $7,798 worth of shares (958 units at $8.14), increasing direct ownership by 8% to 12,599 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    3/13/24 2:32:24 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mcfarland Robert N bought $10,003 worth of shares (1,221 units at $8.19), increasing direct ownership by 14% to 9,715 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    1/2/24 4:28:21 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation (DE) Leadership Updates

    Live Leadership Updates

    View All

    Astrotech Corporation Appoints Nihanth Badugu as Chief Operating Officer

    AUSTIN, Texas, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech"), today announced that it has appointed Nihanth Badugu as Chief Operating Officer ("COO") of the Company. Mr. Badugu's appointment is effective as of August 13, 2025. "The Board is thrilled to promote Mr. Badugu to Chief Operating Officer," stated Thomas B. Pickens III, Chairman and Chief Executive Officer of Astrotech Corporation. "Nihanth has been an invaluable asset to Astrotech since joining us in 2023. His dedication to operational excellence and program management has significantly advanced our objectives. We are confident in his ability to lead our operations as COO a

    8/18/25 4:45:00 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation Appoints Jennifer Cañas as Chief Financial Officer

    AUSTIN, Texas, May 28, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or ("Astrotech"), today announced that it has appointed Jennifer Cañas as Chief Financial Officer ("CFO") of the Company. Ms. Cañas' appointment is effective as of May 22, 2025. "The Board is delighted to promote Ms. Cañas to Chief Financial Officer," stated Thomas B. Pickens III, Chairman and Chief Executive Officer of Astrotech Corporation. "I have worked with Ms. Cañas since 2022 and have found her to be hard working, competent and knowledgeable. Management and the Board of Directors are excited to promote Jennifer to this position as she demonstrated strong leadership and delivered solid

    5/28/25 5:25:00 PM ET
    $ASTC
    $HTO
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Water Supply
    Utilities

    Jaime Hinojosa Resigns as Chief Financial Officer to Work in Family Business

    AUSTIN, Texas, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") announced the resignation of its Chief Financial Officer, Jaime Hinojosa, effective February 14, 2025.   Mr. Hinojosa will continue to serve in the CFO role until February 14, 2025, and after that time will provide transition services to the Company on a consulting basis through June 30, 2025. In connection with this development, the Company and its Board of Directors have appointed Ryan Polk to serve as interim Chief Financial Officer. "I will be moving to Houston to be closer to family and to work for our family business," said Mr. Hinojosa. "I am grateful to Tom Pickens,

    1/24/25 8:30:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Reports First Quarter of Fiscal Year 2024 Financial Results

    AUSTIN, Texas, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech") reported its financial results for the first quarter of fiscal year 2024, which ended September 30, 2023. Financial Highlights & Recent Developments  Astrotech's consolidated balance sheet remains strong with $39 million in cash and liquid investments, which are anticipated to support our research and development, organic growth, and potential acquisition targets.Revenue for the quarter totaled $425 thousand compared to $38 thousand in the first quarter of the prior year due primarily to ongoing fulfillment of the previously announced 17-unit order for the TRACER 1000™ expl

    11/13/23 4:30:30 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    LogicMark Expands its Board of Directors by Naming Carine Schneider and Tom Wilkinson as Company's Innovative Product Pipeline Continues to Grow (Updated with Additional Details)

    LOUISVILLE, Ky., Oct. 31, 2023 (GLOBE NEWSWIRE) -- LogicMark, Inc. (NASDAQ:LGMK) (the "Company"), creator of the most innovative personal safety and security technology designed for the care economy, today announced that Carine Schneider, FGE, and Tom Wilkinson will join as the newest members of its Board of Directors. Ms. Schneider and Mr. Wilkinson both bring decades of corporate governance, finance, operations, technology, M&A, advisory and CEO experience. "I am thrilled to welcome Carine and Tom to our Board of Directors. Carine's demonstrated history of leadership and innovation in the technology and finance sectors, coupled with Tom's extensive experience and influential work with a

    10/31/23 11:54:15 AM ET
    $ASTC
    $LGMK
    $SONM
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Industrial Specialties
    Health Care

    Astrotech Reports Second Quarter of Fiscal Year 2023 Financial Results

    AUSTIN, Texas, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech") reported its financial results for its second quarter of fiscal year 2023, which ended December 31, 2022. Financial Highlights & Recent Developments  Astrotech's consolidated balance sheet remains strong with $46.8 million in cash and liquid investments.Year-to-date revenue totaled $301 thousand and was generated by sales of TRACER 1000™ explosive trace detector (ETD), as well as recurring maintenance services and sales of consumables for the TRACER 1000. The decrease in revenue from the prior fiscal year is primarily the result of Astrotech shifting focus from the

    2/13/23 8:00:54 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Appoints Thomas B. Pickens III as Chief Technology Officer

    AUSTIN, TX, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech") announced today that its Board of Directors has appointed Thomas B. Pickens III to serve as its Chief Technology Officer ("CTO") in conjunction with his current duties as Chief Executive Officer. Tom Wilkinson, Astrotech's lead independent director said, "The appointment of Tom Pickens as CTO more accurately reflects the dual roles he has been managing since the consolidation of our operations in Austin, Texas. He has consistently demonstrated his proficiency in identifying new applications for our Astrotech Mass Spectrometer Technology™ (the "AMS Technology") and is key in the

    2/6/23 8:00:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    ASTROTECH APPOINTS BOB MCFARLAND TO BOARD OF DIRECTORS

    AUSTIN, TX, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) announced today that it has increased the size of its Board of Directors from four to five directors and has appointed Bob McFarland as a director of the Company. Mr. McFarland brings to Astrotech's Board extensive executive management experience with domestic and international enterprises, with a focus on information technology. Mr. McFarland stated, "I am honored to join the Board of Astrotech. I look forward to working closely with my fellow Board members to support the Company's strategic objectives as it continues to advance its mass spectrometry pipeline of opportunities." Mr. McFarland served as an A

    2/1/23 8:00:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Appoints Jim Becker to Board of Directors

    Astrotech Corporation (NASDAQ:ASTC) announced today that it has appointed Jim Becker to its Board of Directors. Mr. Becker brings to Astrotech's Board extensive leadership, with a focus on strategic market growth and expansion, and business process improvements and scaling, along with public speaking and corporate management skills. He will serve on each of the compensation committee, the corporate governance and nominating committee, and the audit committee of the Board of Directors. Mr. Becker stated, "I look forward to joining the Board of Astrotech. With Astrotech's technological portfolio and the culture of the leadership team, I see this as a perfect opportunity to contribute to thei

    6/23/22 5:00:00 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Reports Second Quarter of Fiscal Year 2022 Financial Results

    Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech") reported its financial results for the second quarter of fiscal year 2022, which ended December 31, 2021. Astrotech had its best quarter since sales of 1st Detect's TRACER 1000™ began, with revenue related to the TRACER 1000 up 332% compared to the same period one year ago. After garnering initial traction in the cargo security market due to the TRACER 1000's near-zero false alarm rate, in the second quarter, 1st Detect completed a major milestone by fulfilling its first purchase order for airport security checkpoint and passenger screening. The TRACER 1000 is now deployed in 13 countries worldwide. AgLAB has reached an im

    2/11/22 8:00:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation (DE) Financials

    Live finance-specific insights

    View All

    Astrotech Announces Listing to the GSA as an Approved United States Government Vendor

    Astrotech Announces Listing to the GSA as an Approved United States Government Vendor AUSTIN, Texas, April 08, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation (1st Detect), announce that 1st Detect's TRACER 1000TM is now listed in the U.S. General Services Administration (GSA) IT Schedule 70 under Contract No. GS-35F-250GA with SRI Group LLC, Special Item Number 334290.   IT Schedule 70 is a long-term contract issued by the GSA to commercial technology vendors that allows sales to the U. S. federal government, one of the largest buyers of goods and services in the world. GSA's thoro

    4/8/24 9:00:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech to Showcase the Tracer 1000 Trace Detector at ISC West Conference

    AUSTIN, Texas, April 02, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation, announces that it will be showcasing its TRACER 1000 Narcotics Trace Detector ("NTD") and Explosives Trace Detector ("ETD") at the International Security Conference and Exposition, also known as ISC West, in Las Vegas, Nevada, from April 9-12, 2024, in booth number 2067. The TRACER 1000 is a high-performance laboratory instrument that is powered by the Astrotech Mass Spectrometer Technology™ ("AMS Technology"). Our mass spectrometer is capable of rapid detection of trace levels of narcotic or explosive compounds in

    4/2/24 9:00:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Introduces the "Gold Standard" of Mass Spectrometry into Narcotics Detection Market with its State-of-the-Art Tracer 1000

     AUSTIN, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation, announces that it is currently accepting orders for the Tracer 1000 Narcotics Trace Detector (NTD). The TRACER 1000 NTD is a high-performance laboratory instrument capable of rapid detection of trace levels of narcotic compounds in seconds. Currently, the Company's Tracer 1000 Explosive Trace Detector (ETD) is now found in multiple locations in 14 countries throughout the world. The NTD provides a ruggedized platform that can be applied across various markets including airports, border security, checkpoint, cargo,

    3/25/24 9:00:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    IBN Coverage Initiated for Astrotech Corp.

    LOS ANGELES, Jan. 17, 2024 (GLOBE NEWSWIRE) -- via IBN – Astrotech Corp. (NASDAQ:ASTC), an instrumentation company focused on commercializing its proprietary ATi Mass Spectrometer Technology™ that is now used in airports and agriculture applications throughout the world, today announces it has selected IBN, a multifaceted financial news and publishing company for private and public entities, to assist with its corporate communications initiatives. Through its Astrotech Technology Inc. (ATi) subsidiary, Astrotech owns and licenses proprietary mass spectrometry solutions for a variety of industries and applications. Between 2016 and 2019, the company secured U.S. patents for its technology

    1/17/24 8:30:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Announces Exciting New Technology Application and Introduces New Subsidiary

    AUSTIN, Texas, Dec. 12, 2023 (GLOBE NEWSWIRE) -- - via IBN - Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") announces formation of a wholly owned subsidiary Pro-Control, Inc. ("Pro-Control") and has entered into an exclusive license to use the ATi Mass Spectrometer Technology for chemical manufacturing process control applications. Pro-Control is announcing the introduction of its proprietary Pro-Control Maximum Value ProcessTM ("Pro-Control MVPTM") and the Pro-Control-1000TM mass spectrometer designed to test, measure and increase potency, purity and weight yields in the chemical manufacturing processes, delivering value to our customers by facilitating improved yield

    12/12/23 9:00:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Presents the First Process Control System for Cannabinoid Oil Distillation Systems

    AUSTIN, Texas, Nov. 27, 2023 (GLOBE NEWSWIRE) -- via IBN - Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, AgLAB, Inc., announce the presentation of the AgLAB Maximum Value ProcessTM ("MVPTM") at MJBizCon. This process is a revolutionary process control system proven to increase the potency of ending-weight yields and increase revenue by an average of 32%. MVPTM uses AgLAB's proprietary mass spectrometer and testing method to provide real-time data and feedback, allowing distillers to adjust the parameters (temperature, feed-rate, pressure) and optimize the quality and quantity of each batch of oil. MVPTM is the fastest and most a

    11/27/23 9:04:17 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    ASTROTECH ADOPTS LIMITED-DURATION STOCKHOLDER RIGHTS PLAN

    Austin, Texas, Dec. 21, 2022 (GLOBE NEWSWIRE) --   Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech") today announced that its Board of Directors (the "Board") has unanimously adopted a limited-duration stockholder rights plan (the "Rights Plan") to protect the interests of all stockholders. The Rights Plan is effective immediately. The Board adopted the Rights Plan in response to recent significant accumulations of portions of Astrotech outstanding common stock. The Rights Plan is similar to other rights plans adopted by publicly held companies and is intended to enable all Company stockholders to realize the long-term value of their investment in the Company and is desig

    12/21/22 4:30:00 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Announces Date for Fiscal Year 2022 Annual Meeting and Deadlines for Stockholder Proposals

    Astrotech Corporation (NASDAQ:ASTC) (the "Company") announced its plans to hold its fiscal year 2022 annual meeting of stockholders (the "2022 Annual Meeting") on Tuesday, November 15, 2022. The 2022 Annual Meeting will be held at 9:00 a.m. Central Time. Current plans are for the meeting to be in person in Austin, Texas at the Company's main office. The Company anticipates sending proxy materials for the annual meeting to stockholders in September 2022. Astrotech Corporation 2022 Annual Meeting of Stockholders Astrotech Corporation Main Office 2105 Donley Drive, Suite 100, Austin, Texas 78758 November 15, 2022 Submission of Stockholder Proposals Given that the date of the 2022 Annual Mee

    8/24/22 9:00:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Announces Date for Fiscal Year 2021 Annual Meeting and Deadlines for Stockholder Proposals

    Astrotech Corporation (NASDAQ:ASTC) (the "Company") announced its plans to hold its fiscal year 2021 annual meeting of stockholders (the "2021 Annual Meeting") on Friday, March 25, 2022. The 2021 Annual Meeting will be held at 9:00 A.M. Central Time. Current plans are for the meeting to be in person in Austin, Texas at the AT&T Hotel and Conference Center. The Company anticipates sending proxy materials for the annual meeting to stockholders in February 2022. Astrotech Corporation 2021 Annual Meeting of Stockholders AT&T Hotel and Conference Center 1900 University Avenue, Austin, Texas 78705 March 25, 2022 Submission of Stockholder Proposals Given that the date of the 2021 Annual Meeting

    1/6/22 4:30:00 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation (DE) Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Astrotech Corporation (DE)

    SC 13D - ASTROTECH Corp (0001001907) (Subject)

    6/26/23 4:00:53 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by Astrotech Corporation (DE) (Amendment)

    SC 13G/A - ASTROTECH Corp (0001001907) (Subject)

    2/8/23 5:29:16 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by Astrotech Corporation (DE) (Amendment)

    SC 13G/A - ASTROTECH Corp (0001001907) (Subject)

    2/8/23 4:02:50 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by Astrotech Corporation (DE) (Amendment)

    SC 13G/A - ASTROTECH Corp (0001001907) (Subject)

    1/25/23 9:17:13 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by Astrotech Corporation (DE) (Amendment)

    SC 13G/A - ASTROTECH Corp (0001001907) (Subject)

    8/25/22 12:04:19 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G filed by Astrotech Corporation (DE)

    SC 13G - ASTROTECH Corp (0001001907) (Subject)

    3/3/22 1:30:15 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by Astrotech Corporation (DE) (Amendment)

    SC 13G/A - ASTROTECH Corp (0001001907) (Subject)

    2/14/22 3:14:47 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G filed by Astrotech Corporation

    SC 13G - ASTROTECH Corp (0001001907) (Subject)

    4/19/21 10:19:14 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13D/A filed by Astrotech Corporation

    SC 13D/A - ASTROTECH Corp (0001001907) (Subject)

    3/31/21 2:23:06 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation (DE) SEC Filings

    View All

    Astrotech Corporation (DE) filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ASTROTECH Corp (0001001907) (Filer)

    8/18/25 4:47:38 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation (DE) filed SEC Form 8-K: Leadership Update, Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ASTROTECH Corp (0001001907) (Filer)

    5/28/25 5:26:26 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 10-Q filed by Astrotech Corporation (DE)

    10-Q - ASTROTECH Corp (0001001907) (Filer)

    5/14/25 9:20:19 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation (DE) filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - ASTROTECH Corp (0001001907) (Filer)

    5/13/25 4:33:56 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation (DE) filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ASTROTECH Corp (0001001907) (Filer)

    3/10/25 8:31:49 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation (DE) filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - ASTROTECH Corp (0001001907) (Filer)

    2/28/25 8:32:17 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 10-Q filed by Astrotech Corporation (DE)

    10-Q - ASTROTECH Corp (0001001907) (Filer)

    2/14/25 8:48:46 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation (DE) filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - ASTROTECH Corp (0001001907) (Filer)

    2/14/25 8:47:50 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: Astrotech Corporation (DE) filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K/A - ASTROTECH Corp (0001001907) (Filer)

    1/24/25 4:30:40 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation (DE) filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ASTROTECH Corp (0001001907) (Filer)

    1/23/25 8:30:34 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials